Immunocore Holdings Statistics
Total Valuation
IMCR has a market cap or net worth of $1.91 billion. The enterprise value is $1.51 billion.
Important Dates
The last earnings date was Wednesday, May 7, 2025, before market open.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IMCR has 50.23 million shares outstanding. The number of shares has increased by 1.48% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 50.23M |
| Shares Change (YoY) | +1.48% |
| Shares Change (QoQ) | +3.80% |
| Owned by Insiders (%) | 0.03% |
| Owned by Institutions (%) | 81.24% |
| Float | 37.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.70 |
| Forward PS | 4.94 |
| PB Ratio | 5.04 |
| P/TBV Ratio | 5.05 |
| P/FCF Ratio | 73.34 |
| P/OCF Ratio | 61.44 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.52 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 57.86 |
Financial Position
The company has a current ratio of 6.36, with a Debt / Equity ratio of 1.15.
| Current Ratio | 6.36 |
| Quick Ratio | 6.03 |
| Debt / Equity | 1.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | 16.67 |
| Interest Coverage | -1.59 |
Financial Efficiency
Return on equity (ROE) is -5.86% and return on invested capital (ROIC) is -2.24%.
| Return on Equity (ROE) | -5.86% |
| Return on Assets (ROA) | -1.83% |
| Return on Invested Capital (ROIC) | -2.24% |
| Return on Capital Employed (ROCE) | -3.36% |
| Revenue Per Employee | $676,635 |
| Profits Per Employee | -$43,870 |
| Employee Count | 493 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 2.02 |
Taxes
| Income Tax | -1.15M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.21% in the last 52 weeks. The beta is 0.84, so IMCR's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | -12.21% |
| 50-Day Moving Average | 30.23 |
| 200-Day Moving Average | 31.20 |
| Relative Strength Index (RSI) | 70.94 |
| Average Volume (20 Days) | 497,101 |
Short Selling Information
| Short Interest | 7.95M |
| Short Previous Month | 7.95M |
| Short % of Shares Out | 21.83% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 26.61 |
Income Statement
In the last 12 months, IMCR had revenue of $333.58 million and -$21.63 million in losses. Loss per share was -$0.43.
| Revenue | 333.58M |
| Gross Profit | 322.49M |
| Operating Income | -29.54M |
| Pretax Income | -57.12M |
| Net Income | -21.63M |
| EBITDA | -25.49M |
| EBIT | -29.54M |
| Loss Per Share | -$0.43 |
Full Income StatementBalance Sheet
The company has $837.03 million in cash and $434.00 million in debt, giving a net cash position of $403.04 million or $8.02 per share.
| Cash & Cash Equivalents | 837.03M |
| Total Debt | 434.00M |
| Net Cash | 403.04M |
| Net Cash Per Share | $8.02 |
| Equity (Book Value) | 378.48M |
| Book Value Per Share | 7.54 |
| Working Capital | 799.46M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $31.08 million and capital expenditures -$5.04 million, giving a free cash flow of $26.04 million.
| Operating Cash Flow | 31.08M |
| Capital Expenditures | -5.04M |
| Free Cash Flow | 26.04M |
| FCF Per Share | $0.52 |
Full Cash Flow StatementMargins
Gross margin is 96.68%, with operating and profit margins of -8.85% and -6.48%.
| Gross Margin | 96.68% |
| Operating Margin | -8.85% |
| Pretax Margin | -6.83% |
| Profit Margin | -6.48% |
| EBITDA Margin | -7.64% |
| EBIT Margin | -8.85% |
| FCF Margin | 7.81% |
Dividends & Yields
IMCR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.48% |
| Shareholder Yield | -1.48% |
| Earnings Yield | -1.13% |
| FCF Yield | 1.36% |
Dividend DetailsAnalyst Forecast
The average price target for IMCR is $58.13, which is 52.89% higher than the current price. The consensus rating is "Buy".
| Price Target | $58.13 |
| Price Target Difference | 52.89% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 23.54% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IMCR has an Altman Z-Score of 1.81 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.81 |
| Piotroski F-Score | 4 |